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A female infant, born to first cousin parents, lapsed into coma with severe 
metabolic acidosis on day three of life. The gas chromatographic/mass spectro- 
metric urinary organic acid profile showed marked elevation of the leucine 
metabolites 3-hydroxy-3-methylglutaric, 3-methylglutaconic, 3-methylgluta- 
ric and 3-hydroxy-isovaleric acids. Less than 5% of the normal activity of the 
enzyme 3-hydroxy-3-methylglutaryl CoA lyase was detected in cultured skin 
fibroblasts. The patient's total and free carnitine was initially low but rose to 
normal levels after placing her on nL-carnitine (100 mg kg -I d- 0. On a diet 
providing 87mgkg- ld  -a of leucine and only 25% of total calories as fat 
and 2 gkg -a d -~ protein, the concentration of the urinary organic acids fell 
markedly. She is now 15 months old with normal growth and development. 
This regimen appears effective in the early treatment of 3-hydroxy-3- 
methylglutaric aciduria. 
3-Hydroxy-3-methylglutaric aciduria (McKusick 24645) was first described by Faull 
and colleagues (1976a; 1976b). Thirteen patients with this condition have been 
described to date. This inborn error of metabolism, which is due to deficiency of 
intramitochondrial 3-hydroxy-3-methylglutaryl CoA lyase (HMG-CoA lyase, EC 
4.1.3.4; Clinkenbeard et al., 1975), typically presents with metabolic acidosis, 
hypoglycaemia, hepatomegaly, and feeding and respiratory difficulties. Leucine 
metabolites proximal to the site of enzymatic block accumulate and are excreted 
in the urine. Typically the concentrations of 3-hydroxy-3-methylglutaric, 3- 
methylglutaconic, 3-methylglutaric and 3-hydroxyisovaleric acids are elevated in 
the urine (Faull et al., 1976a; 1976b). Since 3-hydroxy-3-methylglutaric acid is not 
cleaved into acetyl CoA and acetoacetic acid, the metabolic acidosis in these 
patients is not accompanied by ketonuria. Because of the effective renal clearance, 
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only small elevations in serum organic acids may be observed (Duran et al. ,  
1979). Wysocki and colleagues (1976) and Wysocki and Hahnel (1976a; 1976b) 
documented the deficiency of the 3-hydroxy-3-methylglutaryl CoA lyase in skin 
fibroblasts and leukocytes. The placenta and liver were also found to have little 
enzymatic activity in other affected children (Duran et al. ,  1979; Schutgens et al. ,  
1979; Robinson et al. ,  1980; Norman et al. ,  1982). Consanguinity and intermediate 
parental enzyme levels were reported in several cases (Gibson et al. ,  1982; Greene 
et at'., 1984; Wilson et al. ,  1984), thus providing evidence for autosomal recessive 
inheritance. 
We report another infant with this condition who responded to a low fat, low 
protein diet, supplemented with carnitine. 
CASE REPORT 
The 1J-month-old girl presented on day three of life with gasping, duskiness and 
vomiting. On admission she had shallow, slow respirations, hypothermia (34.4°C), 
abdominal distention and a palpable liver (3 cm below the costal margin). She 
showed easy bruising at venipuncture sites. She was the product of a full term 
pregnancy and uncomplicated vaginal delivery to a 22-year-old gravida 2 parity 1 
healthy Arabic woman. The parents are first cousins. The birthweight was 3.54 kg 
and Apgar scores were normal, 9 and 9 at 1 and 5 min respectively. At the time of 
admission the patient was intubated and put on a ventilator. On the second 
day she had a fit for which anticonvulsant therapy was initiated. Laboratory 
investigations included arterial blood gases which showed metabolic acidosis 
(pH7.2, pCO233, bicarbonate 13), requiring intravenous infusion with sodium 
bicarbonate. The blood glucose was normal and urinalysis demonstrated no keto- 
nuria. Total and direct bilirubin were 8.9 and 0.9mgdL -1. The transaminases 
(SGOT, SGPT) and LDH were elevated (640, 262 and 2290 IU L -1 respectively). 
The prothrombin time was increased (26.7/22s) and fibrinogen was decreased 
(117 mg dL- 1). Blood ammonia (233 pmol L- 1), lactic acid (6.1 meq L- 1) and pyr- 
uvic acid (2.7 mg dL -1) were elevated. No evidence of infection was obtained and 
EEG and cranial ultrasound examinations were normal. Because of the history of 
consanguinity and the finding of non-ketotic metabolic acidosis in a comatose baby, 
a metabolic disease was suspected. Urinary gas chromatography/mass spectrometry 
analysis showed massive elevation of organic acids characteristic of 3-hydroxy-3- 
methylglutaric aciduria (Table 1). The patient had initial plasma total and free 
carnitine levels of 28.9 and 7.8/~molL -1. She was put on DL-carnitine, 
100 mg kg -1 d -~, and a 2 g kg -1 d -~ protein diet. Her carnitine concentrations rose 
to 62.6 and 42.7 pmol L -1 (total and free) after four days of therapy. The discharge 
formula provided a daily intake of 2 g kg -~ of protein, 87 mg kg -~ of leucine, 25% 
of total caloric intake as fat and 100 mgkg -~ DL-carnitine. 
METHODS 
The urinary organic acids were profiled by gas chromatography/mass spectrometry 
as the trimethylsilyl derivatives after solvent extraction (Goodman and Markey, 
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1981). Selected ion monitoring mass spectrometry on an HP 5995B GC/MS using 
a Supelco SPB-1 60 m 'mega bore' column was used for quantification of the urinary 
organic acids. The method of standard additions to a normal urine was employed 
to obtain a working curve for each acid which was quantified. 
HMG-CoA lyase activity was determined by two methods using lysates of 
cultured skin fibroblasts from the patient. The direct method utilized [~4C]-HMG- 
CoA as a substrate using a modification of the method of Gibson and colleagues 
(1982), while the indirect method can detect blocks at three steps in the leucine 
pathway. In this coupled assay the combined activities of 3-methylcrotonyl-CoA 
carboxylase (EC 6.4.1.4), 3-methylglutaconyl-CoA hydratase (EC 4.2.1.18) and 3- 
hydroxy-3-methylglutaryl-CoA lyase (EC 4.1.3.4) are determined. 3-methylcrot- 
onyl-CoA and NaH14CO3 are used as substrates and exogenous 3-hydroxybutyrate 
dehydrogenase (EC 1.1.1.30), NADH and ATP are added. 1-[14C]-acetoacetic acid 
is converted to the stable 1-[a4C]-3-hydroxybutyric acid. The free acids are separated 
and quantified by reverse phase HPLC after hydrolysis of the coenzyme A esters. 
RESULTS AND DISCUSSION 
Table 1 shows a marked elevation of 3-hydrox3"-3-methylglutaric, 3-methylgluta- 
conic, 3-methylgtutaric and 3-hydroxyisovaleric acid excretion in the urine. 3- 
hydroxy-3-methylglutaric acid was the major metabolite. Although newborns may 
normally excrete some 3-hydroxy-3-methylglutaric acid in their urine (Lippe et al., 
Table 1 Urinary organic acid excretion (/zg mg creatinine-1) 
Age 3- 3- 3- 3-hydroxy-3- 
hydroxyisovaleric methylglutaric methylglutaconic methylglutaric 
acid acid acid acid 
Day 1 23600 240 6910 17800 
Day 9 0 0 360 827 
Day 15 170 130 914 2830 
Day 30 28 15 I34 910 
2.5months 0 27 194 320 
4.5months 195 70 590 1590 
1982), the urinary excretion of other leucine metabolites and documentation of the 
enzyme deficiency established the diagnosis of 3-hydroxy-3-methylglutaric aciduria. 
Less than 5% of the activity of 3-hydroxy-3-methylglutaryl-CoA lyase was detected 
in lysates of cultured skin fibroblasts (Table 2), and in the coupled assay there was 
no production of 1-[14C]-3-hydroxybutyric acid, thereby localizing the defect to the 
final step in leucine degradation. 
The patient's initial plasma leucine concentration was 90/xmolL -1 (normal: 
77+21), and she required bicarbonate maintenance for the acidosis. Restriction of 
her leucine intake to 87 mg kg -x d- i  resulted in a decrease in the abnormal urinary 
organic acid excretion while preserving an acceptable plasma leucine concentration. 
Carnitine deficiency was found in this patient. Both total and free plasma carnitine 
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Table 2 3-Hydroxy-3-methylglutaryl CoA lyase activity in cultured skin fibroblasts 
Subject 3-hydroxy-3-methylglutaryl- Percentage of simultaneous 
CoA lyase activity control 
(pmol rain- 1 mg protein- l) 
Previous controls (n = 5) 2230+_1060 (mean -+SD) 
Range 1440-3750 
Controls (n = 3) 3840, 3500, 3000 100 
Patient (3 harvests) 94, 126, 141 2.4, 3,6, 4.7 
rose from 28.9 and 7.8/zmol L- a to 62.6 and 42.7 tzmol L- 1, four days after placing 
her on OL-carnitine (100 mg kg - i  d-l). This confirms the previous findings in two 
patients with 3-hydroxy-3-methylglutaric aciduria reported by Chalmers and col- 
leagues (1984a; 1984b). Secondary carnitine deficiency has been reported by other 
investigators associated with a number of inborn errors of metabolism. In 3- 
hydroxy-3-methylglutaric aciduria, acetoacetic acid is not formed and an increased 
intramitochondrial acyl CoA/CoASH results. Acyl CoA moieties will be conju- 
gated with carnitine to form acyl carnitines which are excreted in the urine causing 
secondary carnitine deficiency (Chalmers et al., 1984a; 1984b). Symptoms of carni- 
tine deficiency may overlap with those of Reye's syndrome and 3-hydroxy-3- 
methylglutaric aciduria. These include vomiting, fatigue, muscle weakness and 
altered level of consciousness. Hepatomegaly, hypoglycaemia and elevated liver 
enzymes are also seen. Correction of carnitine deficiency may therefore result in 
clinical improvement. 
Restriction of fat intake in 3-hydroxy-3-methylglutaric aciduria was reported in 
two patients by Berry and colleagues (1981). This should decrease the amount of 
acetoacetate formed, minimizing the demand on acetyl-CoA and thus reducing 
the inhibition of pyruvate carboxylase which controls gluconeogenesis through 
phosphoenolpyruvate. This patient showed marked clinical improvement after the 
adjustment of her diet to limit the intake of total protein (2 g kg -1 d-1), fat (25 % of 
total calories) and leucine (87 mg kg -~ d-~), along with carnitine supplementation. 
She is .currently 15 months old and has demonstrated normal growth and develop- 
ment for her age with only one episode of acute acidosis in the first year of life. 
This was readily controlled with intravenous bicarbonate. 
A C K N O W L E D G E M E N T  
This work was supported in part by grants AM 25548 from the National Institutes of Health 
and C-326 from the March of Dimes, and the Michigan Department of Mental Health 
Genetic Screening Program. 
REFERENCES 
Berry, H. K., Suchy, F., Hunt, M. and Norman, E. Treatment of 3-hydroxy-3-methylglutaric 
aciduria in first cousins. In: Walser, M. and Williamson, J. R. (eds.), Metabolism and 
J. Inher. Metab. Dis, 10 (1987) 
146 Dasouki et al. 
Clinical Implications of Branched Chain Amino and Ketoacids. Elsevier North Holland, 
1981, pp. 405--410 
Chalmers, R. A., Roe, C. R., Stacey, T. E. and Hoppel, C. L. Urinary excretion of L- 
carnitine and acylcarnitines by patients with disorders of organic acid metabolism: 
Evidence for secondary insufficiency of L-carnitine. Pediatr. Res. 18 (1984a) 1325-1328 
Chalmers, R. A., Stacey, T. E., Tracey, B. M., De Sousa, C., Roe, C. R., Millington, D. 
S. and Hoppel, C. L. L-Carnitine insufficiency in disorders of organic acid metabolism: 
Response to L-carnitine by patients with methylmalonic aciduria and 3-hydroxy-3- 
methylglutaric aciduria. J. Inher. Metab. Dis. 7 Suppl. 2 (1984b) 109-110 
Clinkenbeard, K. D., Reeds, W. D., Mooney, R. A. and Lane, M. D. Intracellular 
localization of the 3-hydroxy-3-methylglutaryl coenzyme A cycle enzymes in liver. J. 
Biol. Chem. 250 (1975) 3108-3116 
Duran, M., Schutgens, R. B. H., Ketel, A., Heymans, H., Berntssen, M. W. J., Ketting, 
D. and Wadman, S. K. 3-hydroxy-3-methylglutaryl CoA lyase deficiency: Postnatal 
management following prenatal diagnosis by analysis of maternal urine. J. Pediatr. 95 
(1979) 1004-1007 
Faull, K. F., Bolton, P. D., Halpern, B., Hammond, J. and Danks, D. M. The urinary 
organic acid profile associated with 3-hydroxy-3-methylglutaric aciduria. Clin. Chim. 
Acta 73 (1976b) 553-559 
Faull, K., Bolton, P. D., Halpern, B., Hammond, J., Danks, D., Hahnel, R., Wilkinson, 
S. P., Wysocki, S. J. and Masters, P. L. Patient with defect in leucine metabolism. N. 
Engl. J. Med. 294 (1976a) 1013 
Gibson, K. M., Sweetman, L., Nyhan, W. L., Page, T. M., Greene, C. and Cann, H. M. 
3-hydroxy-3-methylglutaric aciduria: a new assay of 3-hydroxy-3-methylglutaryl CoA 
lyase using high performance liquid chromatography. Clin. Chim. Acta 126 (1982) 171- 
181 
Goodman, S. I. and Markey, S. P. Diagnosis of Organic Acidemias by Gas Chromatography- 
Mass Spectrometry, Liss, New York, 1981, pp. 105-106 
Greene, C. L., Cann, H. M., Robinson, B. H., Gibson, K. M., Sweetman, L., Holm, J. 
and Nyhan, W. L. 3-hydroxy-3-methylglutaric aciduria. J. Neurogenet. 1 (1984) 165-173 
Lippe, G., Galzigna, L,, Francesconi, M., Zorzi, C. and Deana, R. Age-dependent excretion 
of 3-hydroxy-3-methylglutaric acid (HMG) and ketone bodies in the urine of full term 
and pre-term newborns. Clin. Chim. Acta 126 (1982) 291-295 
Norman, E. J., Denton, M. D. and Berry, H. K. Gas chromatographic/mass spectrometric 
detection of 3-hydroxy-3-methylglutaryl CoA lyase deficiency in double first cousins. 
Clin. Chem. 28 (1982) 137-140 
Robinson, B. H., Oei, J., Sherwood, W. G., Slyper, A. H., Heininger, J. and Mamer, O. 
A. Hydroxymethylglutaryl CoA lyase deficiency: Features resembling Reye syndrome. 
Neurology 30 (1980) 714-718 
Schutgens, R. B. H., Heymans, H., Ketel, A., Veder, H. A., Duran, M., Ketting, D. 
and Wadman, S. K. Lethal hypoglycemia in a child with a deficiency of 3-hydroxy-3- 
methylglutaryl CoA-lyase. J. Pediatr. 94 (1979) 89-91 
Wilson, W. G., Cass, M. B., Svik, O., Gibson, K. M. and Sweetman, L. A child with acute 
pancreatitis and recurrent hypoglycemia due to 3-hydroxy-3-methylglutaryl CoA lyase 
deficiency. Eur. J. Pediatr. 142 (1984) 289-291 
Wysocki, S. J. and Hahnel, R. 3-hydroxy-3-methylglutaric aciduria: Deficiency of 3-hydroxy- 
3-methylglutaryl CoA lyase. Clin. Chim. Acta 71 (1976a) 349-351 
Wysocki, S. J. and Hahnel, R. 3-hydroxy-3-methylglutaric aciduria: 3-hydroxy-3-methylglut- 
aryl-Coenzyme A lyase levels in leukocytes. Clin. Chim. Acta 73 (1976b) 373-375 
Wysocki, S. J., Wilkinson, S. P., Hahnel, R., Wong, C. Y. B. and Panegyres, P. K. 3- 
hydroxy-3-methylglutaric aciduria, combined with 3-methylglutaconic aciduria. Clin. 
Chim. Acta 70 (1976) 399-406 
J. Inher. Metab. Dis. 10 (1987) 
